ClinicalTrials.Veeva

Menu

Attenuation of Pain in Men and Women

University of Wisconsin (UW) logo

University of Wisconsin (UW)

Status

Completed

Conditions

Pain

Treatments

Drug: Naltrexone, then placebo
Drug: Placebo, then Naltrexone

Study type

Interventional

Funder types

Other

Identifiers

NCT01220414
H-2010-0087

Details and patient eligibility

About

The purpose of this study is to examine opioid and endocannabinoid mechanisms of exercise-induced analgesia in men and women.

Enrollment

60 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Healthy men and women

Exclusion Criteria:

  • current cardiac or other chronic diseases (e.g., cancer, diabetes, hypertension, kidney disease); routine use of prescriptive medications; history of vasovagal response to phlebotomy; an allergy to naltrexone; pregnancy; current smokers; current use of recreational drugs; history of substance abuse

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

60 participants in 2 patient groups

Men
Active Comparator group
Treatment:
Drug: Placebo, then Naltrexone
Drug: Naltrexone, then placebo
Women
Active Comparator group
Treatment:
Drug: Placebo, then Naltrexone
Drug: Naltrexone, then placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems